284 related articles for article (PubMed ID: 23561594)
1. Combining cancer immunotherapy and targeted therapy.
Ribas A; Wolchok JD
Curr Opin Immunol; 2013 Apr; 25(2):291-6. PubMed ID: 23561594
[TBL] [Abstract][Full Text] [Related]
2. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
Pennock GK; Chow LQ
Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
[TBL] [Abstract][Full Text] [Related]
3. [Combination of Targeted Therapy and Immunotherapy for Cancer].
Kadowaki N
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1046-9. PubMed ID: 26469160
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral immunotherapy: using the tumor as the remedy.
Marabelle A; Tselikas L; de Baere T; Houot R
Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer.
Hughes PE; Caenepeel S; Wu LC
Trends Immunol; 2016 Jul; 37(7):462-476. PubMed ID: 27216414
[TBL] [Abstract][Full Text] [Related]
7. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
8. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy and Immunosuppression in the Tumor Microenvironment.
Allegrezza MJ; Conejo-Garcia JR
Trends Cancer; 2017 Jan; 3(1):19-27. PubMed ID: 28718424
[TBL] [Abstract][Full Text] [Related]
10. Evolving synergistic combinations of targeted immunotherapies to combat cancer.
Melero I; Berman DM; Aznar MA; Korman AJ; Pérez Gracia JL; Haanen J
Nat Rev Cancer; 2015 Aug; 15(8):457-72. PubMed ID: 26205340
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer.
Opzoomer JW; Sosnowska D; Anstee JE; Spicer JF; Arnold JN
Front Immunol; 2019; 10():1654. PubMed ID: 31379850
[TBL] [Abstract][Full Text] [Related]
12. Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.
Michelle Xu M; Pu Y; Weichselbaum RR; Fu YX
Oncogene; 2017 Feb; 36(5):585-592. PubMed ID: 27425593
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Barriers to T Cell Function in Tumors.
Sugiura A; Rathmell JC
J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
[TBL] [Abstract][Full Text] [Related]
14. Modulating MUC1 Function on T Cells.
Erick TK; Mukherjee P
Trends Immunol; 2019 Nov; 40(11):980-983. PubMed ID: 31653412
[TBL] [Abstract][Full Text] [Related]
15. [Combination Therapy of Immune Checkpoint Inhibitors].
Kitano S
Gan To Kagaku Ryoho; 2017 Sep; 44(9):727-732. PubMed ID: 28912397
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy.
Gavali S; Liu J; Li X; Paolino M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639141
[TBL] [Abstract][Full Text] [Related]
17. Role of cell surface proteoglycans in cancer immunotherapy.
Espinoza-Sánchez NA; Götte M
Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
[TBL] [Abstract][Full Text] [Related]
18. Combinations of Bevacizumab With Cancer Immunotherapy.
Chen DS; Hurwitz H
Cancer J; 2018; 24(4):193-204. PubMed ID: 30119083
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement of Cytotoxic T Lymphocytes(CTLs)Infiltration into the Cancer Tissues].
Akazawa Y; Suzuki T; Nakatsura T
Gan To Kagaku Ryoho; 2018 Feb; 45(2):227-231. PubMed ID: 29483410
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
